Association Between Lung Cancer and Pulmonary Tuberculosis: To Be or Not to Be in a TB Burden Country? Clinical Case Series

CHEST Journal ◽  
2013 ◽  
Vol 144 (4) ◽  
pp. 214A
Author(s):  
Oana Deleanu ◽  
Ana-Maria Nebunoiu ◽  
Ruxandra Ulmeanu ◽  
Florin Mihaltan ◽  
Oana Arghir
2013 ◽  
Vol 39 (4) ◽  
pp. 484-489 ◽  
Author(s):  
Denise Rossato Silva ◽  
Dirceu Felipe Valentini Junior ◽  
Alice Manica Muller ◽  
Carlos Podalirio Borges de Almeida ◽  
Paulo de Tarso Roth Dalcin

OBJECTIVE: Lung cancer (LC) is the leading cause of cancer-related death and represents a major public health problem worldwide. Another major cause of morbidity and mortality, especially in developing countries, is tuberculosis. The simultaneous or sequential occurrence of pulmonary tuberculosis and LC in the same patient has been reported in various case series and case-control studies. The objective of this study was to describe the characteristics of patients developing tuberculosis and LC, either simultaneously or sequentially. METHODS: This was a cross-sectional study based on the review of medical charts. RESULTS: The study involved 24 patients diagnosed with tuberculosis and LC between 2009 and 2012. The diagnoses of tuberculosis and LC occurred simultaneously in 10 patients, whereas tuberculosis was diagnosed prior to LC in 14. The median time between the two diagnoses was 5 years (interquartile range: 1-30 years). Fourteen patients (58.3%) were male, 20 (83.3%) were White, and 22 (91.7%) were smokers or former smokers. The most common histological type was adenocarcinoma, identified in 14 cases (58.3%), followed by epidermoid carcinoma, identified in 6 (25.0%). Seven patients (29.2%) presented with distant metastases at diagnosis; of those 7 patients, 5 (71%) were diagnosed with LC and tuberculosis simultaneously. CONCLUSIONS: In the present study, most of the patients with tuberculosis and LC were smokers or former smokers, and tuberculosis was diagnosed either before or simultaneously with LC. Non-small cell lung cancer, especially adenocarcinoma, was the most common histological type.


CHEST Journal ◽  
2012 ◽  
Vol 142 (4) ◽  
pp. 613A
Author(s):  
Oana Deleanu ◽  
Andra Malaut ◽  
Ana Nebunoiu ◽  
Ruxandra Ulmeanu ◽  
Ileana Rohan ◽  
...  

Author(s):  
Pier Poli ◽  
Francisley Avila Souza ◽  
Mattia Manfredini ◽  
Carlo Maiorana ◽  
Mario Beretta

Not required for Clinical case letters according to the authors' guidelines.


Author(s):  
Chandramouli M.T

AbstractLife-threatening adverse reactions of antitubercular drugs are uncommon; however, thrombocytopenia is one such rare complication encountered with rifampicin, isoniazid, ethambutol, and pyrazinamide. Rifampicin is the most effective drug and its use in the tuberculosis treatment led to the emergence of modern and effective short-course regimens. I am reporting case series of three patients with pulmonary tuberculosis presented with rifampicin-induced thrombocytopenia.


Author(s):  
Harveen Kaur

Tuberculosis (TB) is known to mimic several clinical conditions, especially malignancy. Pulmonary TB can present with pulmonary infiltration with or without mediastinal lymphadenopathy. TB often gets misdiagnosed in the countries having a low incidence of TB with a high incidence of lung cancer and varying clinical presentations, which results in delay in treatment initiation and unnecessary diagnostic procedures. We present a case of a 52-year old female, with a presumptive diagnosis of malignancy, which was subsequently proved as pulmonary tuberculosis with no evidence of malignancy instead.


Sign in / Sign up

Export Citation Format

Share Document